Categorized | Stock News

Opexa’s Surge a Headscratcher: BioBuzz

Why are investors glomming onto a multiple sclerosis drug with very iffy data?

View More: http://feeds.thestreet.com/~r/tsc/feeds/rss/latest-stories/~3/zDKKJGUssE0/opexas-surge-a-headscratcher-biobuzz.html

Leave a Reply

You must be logged in to post a comment.

Subscribe to SMS

By confirming my cell number, I agree that I am responsible for all of my carrier text messaging charges.

Partly powered by CleverPlugins.com